itraconazole has been researched along with tacrolimus in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (14.58) | 18.2507 |
2000's | 19 (39.58) | 29.6817 |
2010's | 17 (35.42) | 24.3611 |
2020's | 5 (10.42) | 2.80 |
Authors | Studies |
---|---|
Adibzadeh, M; Friccius, H; Pawelec, G; Pohla, H; Schenk, A; Siegels-Hübenthal, P | 1 |
Demetris, AJ; Gritsch, A; Jordan, M; Katari, SR; Magnone, M; McCauley, J; Randhawa, PS; Scantlebury, V; Shapiro, R; Starzl, T; Vivas, C | 1 |
Bar, I; Bublil, M; Kramer, MR; Merin, G; Milgalter, E; Nesher, T; Rudis, E | 1 |
Cerrina, J; Dartevelle, P; Furlan, V; Ladurie, FL; Parquin, F; Penaud, JF; Taburet, AM | 1 |
Billaud, EM; Chevalier, P; Guillemain, R; Tacco, F | 1 |
Hossain, MA; Kohno, S; Maesaki, S; Marichal, P; Sanglard, D; Vanden Bossche, H | 1 |
Basile, V; Capone, D; Gentile, A; Imperatore, P; Palmiero, G | 1 |
Hurtado, JL; Martín, I; Outeda Macías, M; Salvador, P | 1 |
Higuchi, M; Hora, K; Ideura, T; Kiyosawa, K; Muramatsu, T; Tachibana, N | 1 |
Friedman, GS; Mathis, AS | 1 |
Benito, N; Moreno, A; Puig, J; Rimola, A | 1 |
Cervelli, MJ; Russ, GR | 1 |
Boyle, GJ; Gandhi, S; Kurland, G; Law, YM; Mahnke, CB; Michaels, M; Miller, SA; Pigula, FA; Sutton, RM; Venkataramanan, R; Webber, SA | 1 |
Hasegawa, A; Kano, R; Okabayashi, K; Ozawa, H; Watanabe, S | 1 |
Bakal, I; Kramer, MR; Ollech, A; Ollech, JE; Sahar, G; Saute, M; Shitrit, D | 1 |
Boyette, RM; Leather, H; Tian, L; Wingard, JR | 1 |
Andrew, S; Fitzgerald, D; Singh, MN | 1 |
Gentry, LO; Hamill, RJ; Koo, HL | 1 |
Arima, F; Eto, T; Gondo, H; Kamo, M; Kato, K; Muta, T; Nawata, R; Okeda, A; Oku, S; Shibuya, T; Takase, K | 1 |
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
Dannaoui, E; Lortholary, O; Schwarz, P | 1 |
Aisa, Y; Ikeda, Y; Kato, J; Mori, T; Nakamura, Y; Okamoto, S | 1 |
Aisa, Y; Kato, J; Mori, T; Nakamura, Y; Okamoto, S; Shimizu, T | 1 |
Kagaya, H; Miura, M; Nara, M; Saitoh, H; Sawada, K; Takahashi, N | 1 |
Aomori, T; Araki, T; Fujita, Y; Hiromura, K; Nakamura, T; Nojima, Y; Okada, Y; Shimizu, R; Tomizawa, T; Yamamoto, K | 1 |
Fujishima, N; Hirokawa, M; Kagaya, H; Kameoka, Y; Miura, M; Nara, M; Niioka, T; Saitoh, H; Sawada, K; Tagawa, H; Takahashi, N | 1 |
Kontoyiannis, DP; Shirazi, F | 1 |
Enderby, CY; Heckman, MG; Keller, CA; Thomas, CS | 1 |
Cao, C; Li, X; Liang, H; Mo, D; Sun, C; Wei, L | 1 |
Abumiya, M; Komatsuda, A; Miura, M; Nara, M; Niioka, T; Okuyama, S; Omokawa, A; Takahashi, N; Togashi, M; Wakui, H | 1 |
Bi, KS; Chen, XH; Lu, XF; Zhan, J; Zhou, Y | 1 |
Akashi, K; Ikesue, H; Masuda, S; Matsukawa, K; Miyamoto, T; Shiratsuchi, M; Suetsugu, K; Tsuchiya, Y; Uchida, M; Watanabe, H; Yamamoto-Taguchi, N | 1 |
Gao, L; He, C; Li, M; Sun, Y; Zeng, T | 1 |
Annaert, P; de Hoon, J; de Loor, H; Knops, N; Kuypers, DRJ; Vanhove, T | 1 |
He, Y; Tan, J; Yang, L; Zhang, J | 1 |
Chen-Yoshikawa, TF; Date, H; Imai, S; Masuda, S; Matsubara, K; Matsuda, Y; Nagao, M; Nakagawa, S; Nakagawa, T; Omura, T; Sugimoto, M; Tsuda, M; Tsuzuki, T; Yamamoto, T; Yano, I; Yonezawa, A | 1 |
Hayashi, N; Hirama, T; Kikuchi, M; Kumondai, M; Maekawa, M; Mano, N; Mizuguchi, A; Okada, Y; Sato, T; Sato, Y; Ui, M | 1 |
Abdorahimi, M; Ahmadikia, K; Badali, H; Gharehbolagh, SA; Khodavaisy, S; Mahmoudi, S; Meis, JF; Rezaie, S | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
4 review(s) available for itraconazole and tacrolimus
Article | Year |
---|---|
Coadministration of digoxin with itraconazole in renal transplant recipients.
Topics: Anti-Arrhythmia Agents; Antifungal Agents; Atrial Fibrillation; Digoxin; Drug Interactions; Humans; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Male; Middle Aged; Tacrolimus | 2001 |
Alternariosis after liver transplantation.
Topics: Alternaria; Antifungal Agents; Humans; Immunosuppressive Agents; Itraconazole; Liver Transplantation; Male; Middle Aged; Mycoses; Tacrolimus | 2001 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
5 trial(s) available for itraconazole and tacrolimus
Article | Year |
---|---|
Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
Topics: Antifungal Agents; Drug Costs; Drug Interactions; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Kidney; Lung Transplantation; Mycoses; Postoperative Complications; Tacrolimus | 2005 |
Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adult; Antifungal Agents; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Injections, Intravenous; Itraconazole; Male; Middle Aged; Prospective Studies; Tacrolimus; Transplantation, Homologous | 2006 |
The consequences of tacrolimus blood concentrations during the four weeks following marrow transplantation from an unrelated donor: a single-center experience.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Female; Graft vs Host Disease; Humans; Itraconazole; Male; Middle Aged; Survival Rate; Tacrolimus; Time Factors; Tissue Donors; Transplantation, Homologous | 2008 |
Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.
Topics: Administration, Oral; Adult; Antifungal Agents; Asian People; Chi-Square Distribution; Cyclosporine; Cytochrome P-450 CYP3A; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Genotype; Humans; Immunosuppressive Agents; Itraconazole; Japan; Male; Middle Aged; Pharmacogenetics; Phenotype; Pilot Projects; Polymorphism, Genetic; Prospective Studies; Stem Cell Transplantation; Tacrolimus; Transplantation, Homologous | 2013 |
In vivo CYP3A4 activity does not predict the magnitude of interaction between itraconazole and tacrolimus from an extended release formulation.
Topics: Administration, Oral; Adult; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Delayed-Action Preparations; Drug Interactions; Healthy Volunteers; Humans; Itraconazole; Male; Metabolic Clearance Rate; Midazolam; Prospective Studies; Tacrolimus; Young Adult | 2019 |
39 other study(ies) available for itraconazole and tacrolimus
Article | Year |
---|---|
The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells.
Topics: Antifungal Agents; Cells, Cultured; Cyclosporine; Cytokines; Fluconazole; Gene Expression; Humans; Itraconazole; Ketoconazole; Lymphocytes; Miconazole; Tacrolimus | 1992 |
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Biopsy, Needle; Clarithromycin; Creatinine; Diltiazem; Drug Interactions; Female; Humans; Hyperglycemia; Hyperkalemia; Hypertension; Immunosuppressive Agents; Infusions, Intravenous; Itraconazole; Kidney; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Time Factors; Transplantation, Homologous; Tremor; Ultrasonography; Vasodilator Agents | 1997 |
Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506).
Topics: Antifungal Agents; Costs and Cost Analysis; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Mycoses; Tacrolimus; Transplantation, Homologous | 1997 |
Interaction between tacrolimus and itraconazole in a heart-lung transplant recipient.
Topics: Antifungal Agents; Drug Interactions; Female; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Itraconazole; Middle Aged; Tacrolimus | 1998 |
Evidence for a pharmacokinetic interaction between itraconazole and tacrolimus in organ transplant patients.
Topics: Adolescent; Antifungal Agents; Drug Interactions; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Itraconazole; Liver Transplantation; Lung Transplantation; Male; Retrospective Studies; Tacrolimus | 1998 |
Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genes, MDR; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Tacrolimus | 1998 |
Effects of itraconazole on tacrolimus blood concentrations in a renal transplant recipient.
Topics: Adult; Antifungal Agents; Candidiasis; Drug Interactions; Humans; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Male; Tacrolimus | 1999 |
Tacrolimus-itraconazole interaction in a kidney transplant patient.
Topics: Adult; Antifungal Agents; Drug Interactions; Female; Humans; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Tacrolimus | 2000 |
Tacrolimus/itraconazole interactions: a case report of ABO-incompatible living-related renal transplantation.
Topics: ABO Blood-Group System; Adult; Antifungal Agents; Blood Group Incompatibility; Drug Interactions; Humans; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Living Donors; Male; Tacrolimus | 2000 |
Itraconazole-tacrolimus drug interaction.
Topics: Adult; Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Drug Interactions; Humans; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Male; Pancreas Transplantation; Tacrolimus; Time Factors | 2003 |
Tacrolimus dosage requirements after initiation of azole antifungal therapy in pediatric thoracic organ transplantation.
Topics: Analysis of Variance; Antifungal Agents; Child; Female; Fluconazole; Humans; Immunosuppressive Agents; Itraconazole; Male; Mycoses; Organ Transplantation; Retrospective Studies; Tacrolimus | 2003 |
Antifungal activities of the combination of tacrolimus and itraconazole against Trichophyton mentagrophytes.
Topics: Antifungal Agents; Colony Count, Microbial; Drug Synergism; Itraconazole; Microbial Sensitivity Tests; Tacrolimus; Trichophyton | 2005 |
Solitary cutaneous nodule in an immunocompromised patient.
Topics: Alternaria; Ankle; Dermatomycoses; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Middle Aged; Pyrimidines; Retreatment; Tacrolimus; Triazoles; Voriconazole | 2007 |
Disseminated histoplasmosis manifesting as a soft-tissue chest wall mass in a heart transplant recipient.
Topics: Aged; Amphotericin B; Antifungal Agents; Biopsy; Debridement; Diagnosis, Differential; Drug Administration Schedule; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Histoplasma; Histoplasmosis; Humans; Immunosuppressive Agents; Itraconazole; Male; Mycophenolic Acid; Soft Tissue Infections; Tacrolimus; Thoracic Wall; Tomography, X-Ray Computed; Transplantation Conditioning | 2008 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cyclosporine; Drug Interactions; Immunosuppressive Agents; Itraconazole; Microbial Sensitivity Tests; Mucorales; Rhizopus; Sirolimus; Tacrolimus; Thiazoles; Triazoles | 2009 |
Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole.
Topics: Administration, Oral; Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Itraconazole; Male; Retrospective Studies; Tacrolimus; Transplantation, Homologous | 2009 |
Overcoming the effect of rifampin on the tacrolimus metabolism by itraconazole administration in an allogeneic hematopoietic stem cell transplant recipient.
Topics: Antibiotics, Antitubercular; Antifungal Agents; Drug Interactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Itraconazole; Middle Aged; Myelodysplastic Syndromes; Rifampin; Tacrolimus; Transplantation, Homologous | 2010 |
Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3.
Topics: Administration, Oral; Alleles; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Capsules; Combined Modality Therapy; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dacarbazine; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Graft vs Host Disease; Half-Life; Hodgkin Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Intestines; Itraconazole; Methotrexate; Tacrolimus; Transplantation, Homologous; Vinblastine; Young Adult | 2010 |
Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Itraconazole; Lupus Nephritis; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2013 |
The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosis.
Topics: Antifungal Agents; Apoptosis; Calcineurin Inhibitors; Dose-Response Relationship, Drug; Itraconazole; Mucorales; Tacrolimus; Triazoles | 2013 |
Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole: a preliminary prospective study.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Prognosis; Prospective Studies; Tacrolimus; Voriconazole | 2014 |
In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei.
Topics: Antifungal Agents; Calcineurin Inhibitors; Cyclosporine; Drug Synergism; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Penicillium; Tacrolimus; Yeasts | 2014 |
Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease.
Topics: Adolescent; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B; Connective Tissue Diseases; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Itraconazole; Male; Middle Aged; Polymorphism, Single Nucleotide; Tacrolimus; Young Adult | 2015 |
Use of a semi-physiological pharmacokinetic model to investigate the influence of itraconazole on tacrolimus absorption, distribution and metabolism in mice.
Topics: Animals; Antifungal Agents; Drug Interactions; Immunosuppressive Agents; Itraconazole; Mice; Models, Biological; Random Allocation; Tacrolimus | 2017 |
Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
Topics: Administration, Oral; Adult; Aged; Allografts; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Itraconazole; Male; Middle Aged; Retrospective Studies; Tacrolimus; Voriconazole | 2017 |
Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis.
Topics: Antifungal Agents; Biofilms; Calcineurin Inhibitors; Candida parapsilosis; Drug Synergism; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Phaeohyphomycosis; Tacrolimus; Triazoles; Voriconazole | 2017 |
Tacrolimus, not triamcinolone acetonide, interacts synergistically with itraconazole, terbinafine, bifonazole, and amorolfine against clinical dermatophyte isolates.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Synergism; Humans; Imidazoles; Immunosuppressive Agents; Itraconazole; Microbial Sensitivity Tests; Morpholines; Species Specificity; Tacrolimus; Terbinafine; Triamcinolone Acetonide | 2018 |
Effect of Itraconazole and Its Metabolite Hydroxyitraconazole on the Blood Concentrations of Cyclosporine and Tacrolimus in Lung Transplant Recipients.
Topics: Cyclosporine; Humans; Itraconazole; Lung; Retrospective Studies; Tacrolimus; Transplant Recipients | 2022 |
Therapeutic Drug Monitoring of Blood Sirolimus and Tacrolimus Concentrations for Polypharmacy Management in a Lymphangioleiomyomatosis Patient Taking Two Cytochrome P450 3A Inhibitors.
Topics: Clarithromycin; Cytochrome P-450 CYP3A; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Itraconazole; Lymphangioleiomyomatosis; Middle Aged; Mycophenolic Acid; Polypharmacy; Prednisolone; Sirolimus; Tacrolimus | 2023 |
In vitro combination of antifungal drugs with tacrolimus (FK506) holds promise against clinical Candida species, including Candida auris.
Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candida auris; Candida glabrata; Candida parapsilosis; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Tacrolimus | 2023 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |